(2021)
Albumin neutralizes hydrophobic toxins and modulates Candida albicans pathogenicity.
mBio 12(3),
e0053121.

Dr. Mark Gresnigt
Adaptive Pathogenicity Strategies · Head +49 3641 532-1305 mark.gresnigt@leibniz-hki.deCurriculum vitae
Main Research Areas
- Infection biology of human pathogenic fungi (Candida albicans)
- Immunology of fungal infections
- Host-pathogen interactions
- Fungal adaptation to the host
Professional Career
Since 05/2020 |
Junior Research Group Leader, Leibniz Institute of Natural Product Research and Infection Biology - Hans Knoell Institute, Adaptive Pathogenicity Strategies |
05/2018- 05/2020 |
Alexander von Humboldt Foundation Postdoctoral Fellowship, Leibniz Institute of Natural Product Research and Infection Biology - Hans Knoell Institute, Dept. Microbial Pathogenicity Mechanisms |
03/2018-04/2018 | Language Course German, Dresden, Germany |
08/2015-03/2018 | Postdoctoral researcher, Radboud University Medical Center, Department of Internal medicine, Nijmegen Institute for Infectious Diseases. Project: The development of novel immunomodulatory strategies for disseminated fungal infections |
10/2010-05/2015 | Phd, Radboud University Nijmegen Medical Center, department of internal medicine, Nijmegen, The Netherlands. Project: Pattern recognition and cytokine signalling pathways in the host defence against Aspergillus fumigatus |
02/2008-08/2010 | M.Sc. Medical Biology, Radboud University, Nijmegen, The Netherlands |
07/2003-07/2007 | B.Sc. Biology and Medical Laboratory Research, Saxion University of Applied Sciences, Enschede, The Netherlands |
Awards · Appointments · Scientific Activities
2021 | Research award of the German speaking society for Mycology (DMykG) |
2021 | Science Award Life Sciences and Physics 2021 Beutenberg Campus e.V. Jena |
Since 2021 | Member and PI of the DFG SFB/TR 124 programme "Pathogenic fungi and their human host: Networks of interaction – FungiNet'" |
Since 2020 | DFG Emmy Noether grant |
2020 | Journal of Fungi Travel Award |
2020 | Co-Organizer of the FEBS advanced practical course “State-of-the-art infection models for human pathogenic fungi” in Jena, Germany |
2019 | PLoS Pathogens Postdoctoral Poster Award, Advanced lecture course on Human Fungal Pathogens |
2019 | ESCMID Research Grant 2019 |
2019 | Co-organizer of the winter school of the FunHoMic Marie Curie International Training Network |
2018-2021 | Two publication awards of the Deutschsprachigen Mykologischen Gesellschaft (DMykG; as co-author) |
2018 | Humboldt Research Fellowship for Postdoctoral Researchers |
2018 | Golden pipette award by the Laboratory for Experimental Internal Medicine Radboud University Nijmegen Medical center |
2016 | 3rd prize for best thesis by the Radboud institute for molecular life sciences (RIMLS) |
2015 | Van Beckum thesis Award for best PhD thesis in the field of immunology by the Dutch society for Immunology (NVVI) |
2015 | Youth development Prize by the German speaking society for Mycology (DMykG) |
Since 2014 | Ad hoc reviewer for 19 journals eLife, PLoS Pathogens, mBio, Journal of Infectious Diseases, Frontiers Immunology, Cellular Microbiology, FEMS microbiology letters, Microbial Pathogenesis, Virulence, and others |
2013 | ALLFUN Investigators Award |
Publications
(2021)
Comparative host transcriptome in response to pathogenic fungi identifies common and species-specific transcriptional antifungal host response pathways.
Comput Struct Biotechnol J 19,
647-663.
(2021)
Data of common and species-specific transcriptional host responses to pathogenic fungi.
Data Brief 35,
106928.
(2021)
The anti-inflammatory cytokine interleukin-37 is an inhibitor of trained immunity.
Cell Rep 35(1),
108955.
(2021)
The impact of the Fungus-Host-Microbiota interplay upon Candida albicans infections: current knowledge and new perspectives.
FEMS Microbiol Rev 45(3),
fuaa060.
(Review)
(2021)
Neuraminidase and SIGLEC15 modulate the host defense against pulmonary aspergillosis.
Cell Rep Med 2(5),
100289.
(2021)
Candida albicans-induced leukotriene biosynthesis in neutrophils is restricted to the hyphal morphology.
FASEB J 35(10),
e21820.
(2021)
In vitro infection models to study fungal-host interactions.
FEMS Microbiol Rev 45(5),
fuab005.
(Review)
(2021)
Candida pathogens induce protective mitochondria-associated type I interferon signalling and a damage-driven response in vaginal epithelial cells.
Nat Microbiol 6(5),
643-657.
(2021)
Human albumin enhances the pathogenic potential of Candida glabrata on vaginal epithelial cells.
PLOS Pathog 17(10),
e1010037.